Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week By: TalkMarkets August 27, 2024 at 09:15 AM EDT The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030. Read More >> Related Stocks: AbCellera Biologics Inc. - Common Shares Absci Corporation - Common Stock Exscientia Plc - American Depositary Shares Recursion Pharmaceuticals, Inc. - Class A Common Stock Relay Therapeutics, Inc. - Common Stock Schrodinger, Inc. - Common Stock
